Patents by Inventor Samaresh Sau

Samaresh Sau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12551527
    Abstract: Lipid-based drug delivery vehicles (including liposomal nanoparticles) are described which include antibiotic(s) for the treatment of infections, such as Methicillin-Resistant Staphylococcus (S.) aureus (MRSA) infections and Methicillin-Susceptible S. aureus (MSSA) infections. These drug delivery vehicles have high drug-loading, do not accumulate in the liver, and can optionally include one or more targeting ligands.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: February 17, 2026
    Assignee: Wayne State University
    Inventors: Arun K. Iyer, Samaresh Sau, Michael Rybak, Ketki Bhise, Razie Kebriaei
  • Publication number: 20250049945
    Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.
    Type: Application
    Filed: July 22, 2024
    Publication date: February 13, 2025
    Applicant: Wayne State University
    Inventors: Samaresh Sau, Arun K. Iyer, Hashem Alsaab
  • Patent number: 12083187
    Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: September 10, 2024
    Assignee: WAYNE STATE UNIVERSITY
    Inventors: Samaresh Sau, Arun K. Iyer, Hashem Alsaab
  • Publication number: 20200368313
    Abstract: Lipid-based drug delivery vehicles (including liposomal nanoparticles) are described which include antibiotic(s) for the FIG. 5 treatment of infections, such as Methicillin-Resistant Staphylococcus (S.) aureus (MRSA) infections and Methicillin-Susceptible S. aureus (MSSA) infections. These drug delivery vehicles have high drug-loading, do not accumulate in the liver, and can optionally include one or more targeting ligands.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 26, 2020
    Applicant: Wayne State University
    Inventors: Arun K. Iyer, Samaresh Sau, Michael Rybak, Ketki Bhise, Razie Kebriaei
  • Publication number: 20200338211
    Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.
    Type: Application
    Filed: December 28, 2018
    Publication date: October 29, 2020
    Applicant: Wayne State University
    Inventors: Samaresh Sau, Arun K. Iyer, Hashem Alsaab